Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly buys drug patch for $35m

Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical
Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical.

The drug contains a hormone that stimulates new bone growth. It is designed to be administered with a special device that creates tiny pores in the skin just prior to applying the patch.

Under the terms of the deal, should the patch gain approval, TransPharma will be eligible for milestone payments.

13th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics